Xarelto Lawsuit Filed in New York; Woman Alleges Life Threatening Bleeding from Xarelto, Seeks $10 Million in Damages
St. Louis, MO (PRWEB) December 03, 2014 -- A New York woman has filed a Xarelto lawsuit* against drugmakers Bayer and Janssen Pharmaceuticals, seeking $10 million in damages, report attorneys handling Xarelto lawsuit claims nationwide. According to court documents, the woman alleges she suffered life threatening bleeding while taking Xarelto, an oral anticoagulant. Furthermore, court documents reveal the plaintiff says she has sustained severe and permanent injuries that necessitate medical treatment for the rest of her life. Attorneys handling Xarelto lawsuits for alleged bleeding events provide Xarelto lawsuit news updates at XareltoContingencyLawsuit.com.
This Xarelto lawsuit is one of many such lawsuits underway around the country, as reflected by court documents. Plaintiffs in several Xarelto lawsuits have requested consolidation of similar claims as a multidistrict litigation (MDL); that decision is pending, and will be addressed at this month’s meeting of the U.S. Judicial Panel on Multidistrict Litigation (JPML), set to meet Thursday, December 4 in Charleston, South Carolina, according to court documents.** These lawsuits share in common an assertion that while the drug makers and marketers knew or should have known of the severe bleeding risks associated with Xarelto, the drug continued to be manufactured, distributed, and marketed to American consumers, according to court documents. The lawsuits allege that the risk of bleeding, combined with the fact that there is no known antidote to stop Xarelto bleeding events once commenced, make the drug dangerous and life threatening. Plaintiffs allege they should have been warned of the serious side effects associated with Xarelto, according to court documents.
Xarelto is a blood thinner that fits in the class of oral anticoagulant. Approved by the FDA in 2011, Xarelto is prescribed to patients suffering from atrial fibrillation and recovering from hip and knee replacement surgeries to prevent pulmonary embolism and deep vein thrombosis, according to court documents. While all blood thinners are accompanied by some risk of internal bleeding, court documents indicate that plaintiffs in Xarelto bleeding lawsuits allege Xarelto’s bleeding risks are unreasonable given that the drug has no known antidote. Plaintiffs are seeking damages for their pain, suffering, medical expenses, and wrongful death resulting from severe internal bleeding incidents, according to court documents.
Attorneys handling Xarelto lawsuit claims for the Onder Law Firm provide free case reviews for persons who suffered from internal bleeding or hemorrhagic stroke. Lawyers are investigating these claims for possible Xarelto bleeding lawsuits. The Onder Law Firm is distinguished by a strong track record of wins in medical and pharmaceutical litigation, routinely winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Persons and family members of persons who have suffered from bleeding or hemorrhagic stroke while taking Xarelto are eligible for a no-cost, no-obligation Xarelto lawsuit case review, and may contact the firm through its Xarelto Contingency Lawsuit website.
The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firm’s Xarelto lawyers provide information to the public at http://www.xareltocontingencylawsuit.com.
*Case 1:14-cv-05133-FB-RM, U.S. District Court in Eastern District of New York
**Xarelto Products Liability Litigation (Case No. 2592), under consideration by Judicial Panel on Multidistrict Litigation
Michael Gudeman, Gudeman Group, +1 (314) 614-8709, [email protected]
Share this article